The forecast for malignant neoplasms mortality in Japan indicates a consistent upward trend in deaths from 2024 to 2028, starting at 386.84 thousand deaths in 2024 and increasing incrementally to 394.96 thousand deaths by 2028. The year-on-year growth shows a steady but modest increase, suggesting a persistent rise in mortality rates related to malignant neoplasms. The compound annual growth rate (CAGR) over this five-year period highlights a consistent average annual increase, emphasizing the continuing challenge of malignant neoplasms in Japan’s public health domain.
Future trends to watch for include:
- Advancements in cancer treatments and their influence on mortality rates.
- The impact of early detection programs and increased awareness campaigns on reducing mortality.
- Demographic changes, particularly the aging population, influencing the future incidence and mortality rates.
- Government healthcare policies and investment in research and healthcare infrastructure.
